Drawing for CONFO

USPTO serial 79176060

CONFO

Reviewed by CopyMark Law Group

Reg. 4962136Status 404
Filing date
Status date
Registration date
May 24, 2016
Examiner
RITTNER, HANNO I
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CONFO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D. Hyra

Clifford D. Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for scientific use; Biochemicals for in vitro and in vivo scientific use; biochemical substances in particular antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratoriesSECTION 71 - CANCELLED—
005pharmaceutical and veterinary preparations for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; chemical and biochemical substances for pharmaceutical or veterinary use screened by means of stabilized proteins, namely, small molecules and antibodies for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; veterinary products for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseasesSECTION 71 - CANCELLED—
042scientific research in the field of treating disease; scientific and technological services, namely, research and product design in the field of pharmaceuticals; medical and pharmaceutical research services; laboratory research in the field of pharmaceutical products, particularly the screening of chemical and biochemical substances by means of stabilized proteinsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026IROPIRREGULARITY ON NOTICE OF POSSIBLE OPPOSITION RECEIVED FROM IB—
Jul 13, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 12, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 22, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jan 22, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 12, 2025CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Feb 14, 2025CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jan 31, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 25, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 4, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 4, 2023INPCINVALIDATION PROCESSED—
Aug 9, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 31, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 31, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jan 31, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 31, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 9, 2022C71TCANCELLED SECTION 71—
May 24, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 30, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 19, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 29, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 14, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 25, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Aug 25, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 24, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 8, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2016GPNXNOTIFICATION PROCESSED BY IB—
Feb 17, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 17, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 17, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 28, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 28, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 28, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 28, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 28, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 18, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 4, 2015RFNTREFUSAL PROCESSED BY IB—
Nov 20, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 19, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 19, 2015RFRRREFUSAL PROCESSED BY MPU—
Nov 17, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 16, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2015DOCKASSIGNED TO EXAMINER—
Nov 16, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 15, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance